95-16234. Meeting of the Panel to Assess the NIH Investment in Research on Gene Therapy

[Federal Register Volume 60, Number 127 (Monday, July 3, 1995)]
[Notices]
[Page 34545]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-16234]



-----------------------------------------------------------------------


DEPARTMENT OF HEALTH AND HUMAN SERVICES

Meeting of the Panel to Assess the NIH Investment in Research on 
Gene Therapy

    Notice is hereby given that the Panel to Assess the NIH Investment 
in Research on Gene Therapy, a fact-finding group reporting to the 
Advisory Committee to the Director (ACD), National Institutes of Health 
(NIH), will convene two regional meetings to provide the Panel with an 
opportunity to hear presentations from researchers regarding activities 
relevant to gene therapy. The first meeting will be held at Building 
31C, Conference Room 10, National Institutes of Health, Bethesda, 
Maryland 20892, on July 13, 1995. The second meeting will be held at 
the Sir Francis Drake Hotel on Union Square, 450 Powell Street, San 
Francisco, California 94102, on August 17, 1995. These meetings will 
begin at approximately 9:30 a.m. and will end at approximately 5 p.m.
    The goal of the Panel is to make recommendations to the ACD about 
the scientific areas that NIH should emphasize and the funding 
mechanisms that should be employed in order best to advance the 
development of gene therapy.
    Written statements will be accepted and provided to the Panel prior 
to the meetings. Statements should be sent to Judith H. Greenberg, 
Ph.D., National Institutes of Health, Natcher Building, Room 2AS.19H, 
45 Center Drive MSC 6200, Bethesda, Maryland 20892-6200, or via e-mail 
at [e-mail] or fax at [phone].
    Individuals who plan to attend one of the regional meetings and 
need special assistance, such as sign language interpretation or other 
special accommodations, should contact the person named below in 
advance of the meeting.
    Attendance may be limited to seat availability. If you plan to 
attend the meeting as an observer or if you wish additional 
information, please contact Ms. Janice Ramsden, National Institutes of 
Health, Shannon Building, Room 235, 1 Center Drive MSC 0159, Bethesda, 
Maryland 20892-0159, telephone [phone], fax [phone], e-
mail address [e-mail] by July 7 for the Bethesda meeting 
and August 11 for the San Francisco meeting.

    Dated: June 22, 1995.
Ruth L. Kirschstein,
Deputy Director, National Institutes of Health.
[FR Doc. 95-16234 Filed 6-30-95; 8:45 am]
BILLING CODE 4140-01-P